HOME >> BIOLOGY >> NEWS
UF researchers find painless electrical stimulus helps restore hand movement for stroke patients

GAINESVILLE, Fla., June 26, 2000 -- Leslie McClellan, 68, could barely hold an empty soft drink can with his left hand years after a stroke rendered his left side almost completely useless. Forget about picking up a piece of paper or grasping a pencil -- or, worse yet, preparing meals.

Now he can anchor a piece of steak with a fork to cut it and once again clutch an apple.

The turnabout came after McClellan participated in a University of Florida study that used a slight electrical current to painlessly stimulate the muscles of his arm. He was one of several who regained some use of their affected fingers, hand and arm after undergoing the therapy, among the experimental rehabilitation techniques scientists say could revolutionize the way patients are treated in the months and years after a stroke, a leading cause of motor disability.

Every 53 seconds, someone in the United States has a stroke, according to the American Heart Association. About 600,000 Americans will suffer one this year, and 160,000 of them will die.

Known as electromyography-triggered neuromuscular electrical stimulation, the approach is thought to retrain the brain to control voluntary movements, which often are impeded by a stroke, said James Cauraugh, an associate professor of exercise and sport sciences in UF's College of Health and Human Performance.

"It's important to work on the wrist and fingers because often they are in a state of flexion; that's when the fingers, the wrist and the elbow are all curled up close to the body," Cauraugh said. "Patients have the tendency to only grab things, rather than to extend their fingers, which often want to stay in a fist. They aren't able to activate the control, to turn on the muscles to extend those fingers."

So Cauraugh and colleagues from UF's College of Health Professions -- including physical therapists Kathye Light and Andrea Behrman -- set out to determine whether a small electrical stimulus could activate arm musc
'"/>

Contact: Melanie Fridl Ross
ufcardiac@aol.com
352-690-7051
University of Florida
25-Jun-2000


Page: 1 2 3 4

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:
(Date:5/21/2013)... occur in the body, stem cells in the ... differentiating into mature immune cells that can fight ... deplete these cell populations, potentially leading to the ... Now, a team of researchers led by biologists ... found that, in mouse models, the molecule microRNA-146a ...
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... new University of Michigan Water Center today awarded ... Great Lakes restoration and protection efforts. , The ... diverse projects, including efforts to track the remediation ... techniques to control non-native weedy plant invasions; study ... fish responses to restoration activities. , The grants ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
(Date:5/21/2013)... Wisc. (PRWEB) May 21, 2013 ... parts distributor , will be exhibiting for the ... Advancement of Medical Instrumentation (AAMI) 2013 Conference and ... purchase, support, distribute, and manufacture healthcare technologies. This ... in Long Beach, California. , The three-day ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: